A new site in Seattle has begun enrolling patients in an early-stage clinical trial testing CER-1236, an experimental cell therapy for difficult-to-treat blood cancers, including myelofibrosis. The activation of the Fred Hutch Cancer Center…

As a health and life sciences reporter and a patient advocate for people living with rare cancers, including my own myelofibrosis (MF), I share people’s insights about living with a chronic cancer. If just…

Splenectomy, the surgical removal of the spleen, remains a safe and effective treatment option for certain people with myelofibrosis and other blood-related diseases, according to a 27-year case review from a single Australian teaching…